Recombinomics | Elegant Evolution






Home Founder What's New In The News Consulting





























H1N1 Consulting

Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents



Audio:Feb13 Feb18 Mar18 Mar31 RSS Feed twitter News Now                         
Live feed of underlying pandemic map data here
Commentary


pH1N1 D225G In 2010 North Carolina and Wyoming Sequences

Recombinomics Commentary 13:24
April 7, 2010

The CDC has release another series of sequences at GISAID, from 83 patients in the US.  Most were from the end of 2009 or beginning of 2010 (44 were from 2010),  These sequences included additional low reactors and three sequences with D225G, including the first report 2010 US sequence, A/North Carolina/03/2010,  as well as the second, A/Wyoming/01/2010.  One of the 2009 sequences, A/Washington/68/2009, also had D225G.

These isolates represent an increase in D225G frequencies in more recent cases.  The first 2010 sequence, A/Karasuk/01/2010, had D225G and three 2010 isolates from Greece had D225G (A/Thessaloniki/206/2010, A/Thessaloniki/225/2010, A/Kavala/291/2010).  These increases were expected, based on the report from Mill Hill indicating D225G created a low reactor.

Last fall, D225G was found in isolates (A/North Carolina/39/2009 and A/North Carolina/49/2009) from the index case of the Duke death cluster, as well as another isolate collected in the same time frame, but had the Ukraine marker, A1281G.  This marker is fairly widespread and was also in the 2010 isolate from North Carolina.

The CDC has discounted the strong linkage of D225G to severe and fatal cases, and has yet to acknowledge D225G or D225N in the Duke death cluster were 3 of the 4 patients died, and 3 of the four sequences from these patients had D225G or D225N.  The Duke cluster sequences had H274Ym as well as a rare HA polymorphism, Y233H, and represents yet another genetic background with D225G.  The number of genetic backgrounds with D225G is large, signaling recombination.

Anecdotal reports have described sever cases of H1N1 in younger patients in Georgia, and the P&I deaths for Atlanta had a spike in deaths a month ago.

The latest sequences increase concerns that D225G will be more common in 2010 and will be linked to more severe and fatal cases.

Media Links

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings
















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2010 Recombinomics.  All rights reserved.